Mucopolysaccharidosis, Type Ii (MPS2)

Alias:

Hunter Syndrome

Iduronate 2-Sulfatase Deficiency

Mucopolysaccharidosis Ii

Mucopolysaccharidosis Type Ii

Mps Ii

Mps2

Sulfoiduronate Sulfatase Deficiency

Mucopolysaccharidosis, Mps-Ii

Mucopolysaccharidosis Type 2

Mucopolysaccharidosis Type 2, Severe Form

Sids Deficiency

Ids Deficiency

Mpsii

Mucopolysaccharidosis Type Ii, Attenuated Form

Mucopolysaccharidosis Type 2, Attenuated Form

Mucopolysaccharidosis Type Ii, Severe Form

Iduronate 2-Sulfatase Deficiency Type B

Iduronate 2-Sulfatase Deficiency Type a

Sulphoiduronidate Sulphatase Deficiency

Sulpho-Iduronate Sulphatase Deficiency

Sulfoiduronidate Sulfatase Deficiency

Deficiency of Iduronate-2-Sulphatase

Sulfo-Iduronate Sulfatase Deficiency

Iduronate 2-Sulphatase Deficiency

Iduronate-2-Sulfatase Deficiency

Mps2 - [mucopolysaccharidosis 2]

Iduronate Sulphatase Deficiency

Mucopolysaccharidosis Type Iib

Mucopolysaccharidosis Type Iia

Iduronate Sulfatase Deficiency

Mucopolysaccharidosis Type 2b

Mucopolysaccharidosis Type 2a

Mps Ii - Hunter Syndrome

Mucopolysaccharidosis 2

Hunter Syndrome Type B

Hunter Syndrome Type a

Hunter's Syndrome

Hunters Syndrome

I2s Deficiency

Mpsiib

Mpsiia

Mps2b

Mps2a

Favorite

Basic Information

Medical Symptom

Gene & Mutation

Related Drugs

Disease Model

References Literature

Mucopolysaccharidosis, Type Ii, also known as hunter syndrome, is related to mucopolysaccharidosis with skin involvement and mucopolysaccharidosis-plus syndrome, and has symptoms including diarrhea, hoarseness and seizures. An important gene associated with Mucopolysaccharidosis, Type Ii is IDS (Iduronate 2-Sulfatase), and among its related pathways/superpathways are Metabolism and Glycosaminoglycan metabolism. The drugs Rituximab and Methotrexate have been mentioned in the context of this disorder. Affiliated tissues include spinal cord and skin, and related phenotypes are macrocephaly and muscle weakness

Related ID：

MALACARDS：MCP050

OMIM：309900

MESH：D016532

ICD11：1056274204